https://origin.rootz.global/api/company/MCK| Name | Type | Description |
|---|---|---|
| McKesson Connect | platform | Internet-based ordering system providing real-time inventory availability, ordering, purchasing, third-party reconciliation, and account management. |
| Central Fill | service | Prescription refill service enabling pharmacies to remotely refill prescriptions faster, accurately, and at lower cost. |
| Health Mart | platform | National franchise network of ~4,400 independently-owned pharmacies offering business operations, marketing, and audit support solutions. |
| Health Mart Atlas | service | Managed care services connecting community pharmacies, health systems, and physician practices to competitive reimbursement rates. |
| McKesson Reimbursement Advantage (MRA) | service | Reimbursement optimization package including financial services, analytic services, and customer care for pharmacies. |
| McKesson Provider Pay | software | Automated reconciliation and payment management solution to maximize third-party cash flow and pursue unpaid claims. |
| McKesson OneStop Generics | service | Generic pharmaceutical purchasing program offering broad drug selection and competitive pricing for pharmacies. |
| McKesson SynerGx | service | Generic pharmaceutical purchasing and inventory management program to maximize cost savings for retail national accounts. |
| ExpressRx Track | hardware | Pharmacy automation solution featuring robotics, upgraded imaging, and expanded vial capabilities for speed and accuracy. |
| Pinpoint Community Solutions | software | Perpetual inventory management system for independent pharmacy owners with five or fewer stores. |
| Partner | Type | Description |
|---|---|---|
| Walmart Inc. | strategic | Joint venture ClarusONE Sourcing Services LLP for sourcing generic pharmaceutical drugs. |
| Centers for Disease Control and Prevention (CDC) | strategic | Exclusive distributor relationship for the CDC Vaccines for Children program. |
| SCRI Oncology, LLC | strategic | McKesson owns 51% controlling interest in oncology research network enhancing clinical trial access nationwide. |
View all SEC EDGAR filings: EDGAR Company Page
Structured filing index: /api/company/MCK/filings